GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
about
Testing the excitation/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes.Medial Frontal Lobe Neurochemistry in Autism Spectrum Disorder is Marked by Reduced N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate + Glutamine Levels.Genetic disorders and neurobehavioural phenotypes.Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.
P2860
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@en
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@nl
type
label
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@en
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@nl
prefLabel
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@en
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@nl
P2093
P2860
P50
P1433
P1476
GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
@en
P2093
José Rebola
Miguel Patricio
Nuno Ferreira
P2860
P304
P356
10.1212/WNL.0000000000003044
P407
P577
2016-07-29T00:00:00Z